NCT02016846

Liraglutide Efficacy on Glucocorticoid Induced Hyperglycemia in Patients High Risk for Diabetes

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 36 (estimated)
• Sponsor: Rabin Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Glucocorticoids therapy exposes the patient to an increased risk for diabetes morbidity. However, there is no proven preventive therapy. GLP-1-RA has shown to improve glucose metabolism in healthy volunteers treated with glucocorticoids. We assume that GLP-1-RA will improve glucose metabolism in patients with high risk for diabetes morbidity, treated with glucocorticoids.

Conditions

• Glucocorticoid Induced Hyperglycemia

Interventions

Type	Name	Description
DRUG	Liraglutide
DRUG	Placebo

Timeline

• Start date: 2014-01-01
• Primary completion: 2015-01-01
• First posted: 2013-12-20
• Last updated: 2013-12-24

Locations

1 site across 1 country: Israel